Blood Donors

• 

  Subject Areas on Research

  • 2-(Diethylhexyl)phthalate in blood bags: is this a public health issue? 
  • A motivational interview promotes retention of blood donors with high internal motivation. 
  • A prospective evaluation of chronic Babesia microti infection in seroreactive blood donors. 
  • A randomized controlled trial of a tablet-based intervention to address predonation fears among high school donors. 
  • Acceptability and feasibility of a culturally tailored Internet-delivered intervention to promote blood donation in Blacks. 
  • Access, entanglement, and prosociality. 
  • Alternate analysis strategies for retrospective assessment of outcomes with a male donor-only plasma policy. 
  • An automated motivational interview promotes donation intention and self-efficacy among experienced whole blood donors. 
  • Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donors. 
  • Apheresis for collection of Ebola convalescent plasma in Liberia. 
  • Applying self-determination theory to the blood donation context: The blood donor competence, autonomy, and relatedness enhancement (Blood Donor CARE) trial. 
  • Association of blood donation with iron deficiency among adolescent and adult females in the United States: a nationally representative study. 
  • Autologous blood use for free flap breast reconstruction: a comparative evaluation of a preoperative blood donation program. 
  • Blood banks, biobanks, and the ethics of donation. 
  • Blood donation and blood transfusion: special considerations for African Americans. 
  • Blood donations motivators and barriers: a descriptive study of African American and white voters. 
  • COVID19 antibody detection using lateral flow assay tests in a cohort of convalescent plasma donors. 
  • Carboxyhemoglobin levels in banked blood. 
  • Carboxyhemoglobinemia in a pediatric cardiopulmonary bypass patient derived from a contaminated unit of allogenic blood. 
  • Cardiovascular disease risk assessment and prevention in blood donors. 
  • Chagas Disease Screening in Maternal Donors of Publicly Banked Umbilical Cord Blood, United States. 
  • Changes in protein-bound, complex-bound, and ionized calcium related to parathyroid hormone levels in healthy donors during plateletapheresis. 
  • Characterization of human anti-porcine "natural antibodies" recovered from ex vivo perfused hearts--predominance of IgM and IgG2. 
  • Comparison of the platelet activation status of single-donor platelets obtained with two different cell separator technologies. 
  • Contribution of attitudinal factors to blood donation in African American church attendees. 
  • Cord-blood transplants from unrelated donors in Hurler's syndrome. 
  • Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. 
  • Correlation of West Nile Virus Incidence in Donated Blood with West Nile Neuroinvasive Disease Rates, United States, 2010-2012. 
  • Cost-effectiveness of blood donor screening for Babesia microti in endemic regions of the United States. 
  • Critical evaluation of informed consent forms for adult and minor aged whole blood donation used by United States blood centers. 
  • Demographic differences in estimated blood donor eligibility prevalence in the United States. 
  • Demographic patterns of blood donors and donations in a large metropolitan area. 
  • Demographic variations in blood donor deferrals in a major metropolitan area. 
  • Deployment of convalescent plasma for the prevention and treatment of COVID-19. 
  • Detection of platelet isoantibodies by (3H)serotonin platelet release and its clinical application to the problem of platelet matching. 
  • Determination of Babesia microti seroprevalence in blood donor populations using an investigational enzyme immunoassay. 
  • Development of a multisystem surveillance database for transfusion-transmitted infections among blood donors in the United States. 
  • Development of common metrics for donation attitude, subjective norm, perceived behavioral control, and intention for the blood donation context. 
  • Donating blood on a regular basis appears to reduce blood pressure, but appearances can be deceiving. 
  • Donor Iron Deficiency Study (DIDS): protocol of a study to test whether iron deficiency in blood donors affects red blood cell recovery after transfusion. 
  • Donor glucose-6-phosphate dehydrogenase deficiency decreases blood quality for transfusion. 
  • Donor incentives improve cardiovascular disease risk profile and donation rates. 
  • Donor leukocyte infusions in recurrent Hodgkin lymphoma following allogeneic stem cell transplant: 10-year experience at the M. D. Anderson Cancer Center. 
  • Drug resistance and HCV coinfection in former blood donors infected with HIV type 1 in China. 
  • Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study. 
  • Effectiveness of preoperative autologous blood donation for protection against allogeneic blood exposure in adult spinal deformity surgeries: a propensity-matched cohort analysis. 
  • Essential Role of Patient Blood Management in a Pandemic: A Call for Action. 
  • Ethical issues in umbilical cord blood banking. Working Group on Ethical Issues in Umbilical Cord Blood Banking. 
  • Evaluating a program to increase blood donation among racial and ethnic minority communities in New York City. 
  • Evaluating the role of blood collection centers in public health: a status report. 
  • Evaluation of the Abbott m2000rt RealTime HIV-1 assay with manual sample preparation compared with the ROCHE COBAS AmpliPrep/AMPLICOR HIV-1 MONITOR v1.5 using specimens from East Africa. 
  • Examination of the relationship between iron status and cognitive function among healthy young women with and without a recent history of blood donation. 
  • Fatty acid desaturase activity in mature red blood cells and implications for blood storage quality. 
  • First cases of Zika virus-infected US blood donors outside states with areas of active transmission. 
  • Foundation for the Accreditation of Hematopoietic Cell Therapy (FAHCT) response to FDA (Docket no. 97N-0068). FAHCT Board of Directors. 
  • Frequency of rare, serious donor reactions: International perspective. 
  • Global sources of cryoprecipitate demonstrate variability in coagulant factor levels and functional hemostasis. 
  • Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. 
  • How do I provide leukapheresis products? Blood center experience and evidence for process improvement. 
  • How do we manage blood donors and recipients after a positive Zika screening result? 
  • Impact of predictive scoring model and e-mail messages on African American blood donors. 
  • In reply. 
  • In vivo and in vitro characteristics of double units of RBCs collected by apheresis with a single in-line WBC-reduction filter. 
  • Incidence of Herpesvirus hominis antibodies among blood donor populations. 
  • Large-scale mobilization and isolation of CD34+ cells from normal donors. 
  • Long antibody HCDR3s from HIV-naïve donors presented on a PG9 neutralizing antibody background mediate HIV neutralization. 
  • Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients. 
  • Management of Blood Product Market Withdrawals - A Single Institution's Process and Experience. 
  • Many, but not all, outcome studies support exclusion of female plasma from the blood supply. 
  • Measuring the processes of change for increasing blood donation in black adults. 
  • Minority and foreign-born representation among US blood donors: demographics and donation frequency for 2006. 
  • Minority donation in the United States: challenges and needs. 
  • Motivations for donating and attitudes toward screening policies in US blood donors with viral infection. 
  • Motivators and barriers to blood donation in African American college students. 
  • No association between donor age and recipient outcomes: transfusion of plasma in patients undergoing coronary artery bypass grafting surgery. 
  • Noninvasive white blood cell quantification in umbilical cord blood collection bags with quantitative oblique back-illumination microscopy. 
  • Optimization of informed consent for umbilical cord blood banking. 
  • Optimizing donor selection for public cord blood banking: influence of maternal, infant, and collection characteristics on cord blood unit quality. 
  • Pediatric large-volume leukapheresis: a single institution experience with heparin versus citrate-based anticoagulant regimens. 
  • Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. 
  • Platelet factor 4/heparin antibodies in blood bank donors. 
  • Prevalence of HTLV-I-associated T-cell lymphoma. 
  • Proceedings From the Society for Advancement of Blood Management Annual Meeting 2017: Management Dilemmas of the Surgical Patient-When Blood Is Not an Option. 
  • Profiles of neutralizing antibody response in chronically human immunodeficiency virus type 1 clade B'-infected former plasma donors from China naive to antiretroviral therapy. 
  • Public attitudes to the storage of blood left over from routine general practice tests and its use in research. 
  • Racial differences in motivators and barriers to blood donation among blood donors. 
  • Rapid and Efficient Generation of Transgene-Free iPSC from a Small Volume of Cryopreserved Blood. 
  • Rapid freezing of whole blood or buffy coat samples for polymerase chain reaction and cell culture analysis: application to detection of human immunodeficiency virus in blood donor and recipient repositories. The Transfusion Safety Study Group. 
  • Recent viral infection in US blood donors and health-related quality of life (HRQOL). 
  • Red cell transfusion in the newborn. Indications and unique blood banking needs. 
  • Redirection of Cord Blood T Cells and Natural Killer Cells for Elimination of Autologous HIV-1-Infected Target Cells Using Bispecific DART® Molecules. 
  • Remunerating donors to ensure a safe and available blood supply. 
  • Responding to the immunoglobulin shortage: a case study. 
  • Results of the cord blood transplantation (COBLT) study unrelated donor banking program. 
  • Risk factors for retrovirus and hepatitis virus infections in accepted blood donors. 
  • Risk-based decision making and ethical considerations in donor compensation for plassma-derived medicinal products 
  • Safety of blood donation by individuals over age 70 and their contribution to the blood supply in five developed countries: a BEST Collaborative group study. 
  • Screening of blood donors for sickle cell trait using a DNA-based approach: Frequency in a multiethnic donor population. 
  • Serologic screening of United States blood donors for Babesia microti using an investigational enzyme immunoassay. 
  • Sociodemographic and behavioral characteristics associated with blood donation in the United States: a population-based study. 
  • Spotlight on pathogenesis of TRALI: HNA-3a (CTL2) antibodies. 
  • Stress and coping in HIV-positive former plasma/blood donors in China: a test of cognitive appraisal theory. 
  • Surveillance for Spotted Fever Group Rickettsial Infections: Problems, Pitfalls, and Potential Solutions. 
  • T-Scan: A Genome-wide Method for the Systematic Discovery of T Cell Epitopes. 
  • The African American church as a donation site: motivations and barriers. 
  • The Cord Blood Apgar: a novel scoring system to optimize selection of banked cord blood grafts for transplantation (CME). 
  • The blood donor identity survey: a multidimensional measure of blood donor motivations. 
  • The contribution of sociodemographic, medical, and attitudinal factors to blood donation among the general public. 
  • The impact of age and sex on first-time donor return behavior. 
  • The integration of high-throughput testing of blood donors for cardiovascular disease risk assessment and prevention. 
  • The value of area-based analyses of donation patterns for recruitment strategies. 
  • Transfusion medicine: the problem of HIV infection. 
  • Transfusion-transmitted babesiosis: achieving successful mitigation while balancing cost and donor loss. 
  • Transplant outcomes in mucopolysaccharidoses. 
  • Trends in US minority red blood cell unit donations. 
  • Trends in age and red blood cell donation habits among several racial/ethnic minority groups in the United States. 
  • Trends in antigen-negative red blood cell distributions by racial or ethnic groups in the United States. 
  • Trends in platelet distributions from 2008 to 2017: a survey of twelve national and regional blood collectors. 
  • Umbilical cord blood donation: public or private? 
  • Understanding disparities in donor behavior: race and gender differences in willingness to donate blood and cadaveric organs. 
  • Untying the Gordian knot: policies, practices, and ethical issues related to banking of umbilical cord blood. 
  • Use of a rapid electronic survey methodology to estimate blood donors' potential exposure to emerging infectious diseases: Application of a statistically representative sampling methodology to assess risk in US blood centers. 
  • West Nile virus infection in blood donors in the New York City area during the 2010 seasonal epidemic. 
  • Why has Borrelia burgdorferi not been transmitted by blood transfusion? 
  • Zika Virus and the Blood Supply: What Do We Know?